Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Testim patent?

See the DrugPatentWatch profile for Testim

What patent is “Testim,” and what does it cover?

“Testim” is a brand name for testosterone gel. Patent coverage for the product depends on the specific claim set (drug substance, formulation, method of use, or device/packaging) and the jurisdiction. The exact patent(s) you mean (number and country) matter because different patents can control different parts of market exclusivity.

How can I find the exact Testim patent number?

To get the right patent, you usually need either:
- the patent holder (company name),
- the country (US, EU, etc.),
- and the patent type (drug/formulation vs. method of use).

Common ways people search include looking up:
- the FDA Orange Book record for Testim in the US (this lists patents tied to the approved product), or
- national patent office databases for “Testosterone gel” and “Testim” with the assignee.

If you share the country (and ideally the patent holder or an FDA label link), I can help narrow down which patent numbers are most relevant.

When does the Testim patent (or exclusivity) expire?

Patent expiry dates vary by:
- which specific patent is being referenced,
- patent term adjustments/extensions,
- and any regulatory exclusivity periods that can extend time to generic entry beyond the earliest patent date.

Without the exact patent number or jurisdiction, there is no single reliable “the Testim patent expires on X date” answer.

Are there generics/biosimilars or “authorized” alternatives for Testim?

For testosterone gels, the practical question most people are after is whether a generic can be marketed and when. That depends on:
- whether key formulation/method patents are still active,
- whether FDA approval is for a generic product,
- and any litigation or “carve-outs” that delay launch.

Is Testim still protected by active patents that block generics?

This depends on the current status of each listed patent (expired, active, under challenge, or subject to injunctions). Patent status must be checked per jurisdiction and per patent number.

---

If you tell me which you mean by “Testim patent” (country like US/EU and any patent number, assignee/company name, or a link to the listing you saw), I can pinpoint the specific patent and its likely expiration timing and what it covers.



Other Questions About Testim :

Testim cost? Testim gel price? Testim gel cost? Testim price?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The provided response’s claim (“WARNING: Secondary exposure to testosterone”) is directly supported by the supplied FDA label excerpts (Sections 5.1, 2.2, 6.2, 17.2), including the precautions and postmarketing reports.


Category Scores

Warnings
100
Excellent
Warnings
100
Excellent
Warnings
100
Excellent
Warnings
100
Excellent

Accurate Statements

Secondary exposure to testosterone is addressed as a warning in the TESTIM prescribing information, including that cases of secondary exposure resulting in virilization of children have been reported.
Label excerpts: Section 5.1 (and reiterated in 17.2) stating cases of secondary exposure causing virilization of children have been reported.
Children and women should avoid contact with unwashed or unclothed application sites in men using TESTIM.
Label excerpts: Section 5.1; also supported by Section 2.2 and Section 17.2 precautions.
The label includes precautions to minimize secondary exposure (e.g., hand washing, covering the application site after gel dries, washing application sites before anticipated skin-to-skin contact).
Label excerpts: Section 2.2 administration/precautions and Section 17.2 steps to prevent secondary exposure.
Postmarketing experience includes secondary exposure to testosterone in children, with described signs/symptoms and possible routes (direct contact; possibly via shirts/fabric in at least one case).
Label excerpt: Section 6.2 postmarketing experience describing secondary exposure in children and mention of reported items such as shirts/fabric.

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The response only evaluates and summarizes the existence/support of the secondary exposure warning and related precautions as stated in the label; it does not provide dosing or new clinical instructions beyond label-consistent precautions.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
34
Visibility
40
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

“Testim” is a brand name for testosterone gel.


Core Claims
  • “Testim” is a brand name for testosterone gel.
  • Patent coverage for the product depends on the specific claim set and the jurisdiction.
  • To get the right patent, you usually need the patent holder, country, and patent type.
  • Without the exact patent number or jurisdiction, there is no single reliable answer for when the Testim patent expires.
Differentiators
  • Patent(s) needed are driven by claim set (drug substance, formulation, method of use, or device/packaging) and jurisdiction.
  • Searching guidance references FDA Orange Book records tied to the approved product.

Pricing Perception: Not Mentioned